Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators
Stefano Ponzano, Giulia Nigrelli, Laura Fregonese, Irmgard Eichler, Fabio Bertozzi, Tiziano Bandiera, Luis J.V. Galietta, Marisa Papaluca

European Respiratory Review Jun 2018, 27 (148) 170124; DOI: 10.1183/16000617.0124-2017
How best to capture the respiratory consequences of prematurity?
Francesca Ciuffini, Colin F. Robertson, David G. Tingay

European Respiratory Review Mar 2018, 27 (147) 170108; DOI: 10.1183/16000617.0108-2017
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, Joseph Ciccolini, Laurent Greillier, Nicolas Andre, Fabrice Barlesi, Celine Mascaux

European Respiratory Review Mar 2018, 27 (147) 170098; DOI: 10.1183/16000617.0098-2017
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Sean Gaine, Vallerie McLaughlin

European Respiratory Review Dec 2017, 26 (146) 170095; DOI: 10.1183/16000617.0095-2017
Long-term macrolides in diffuse interstitial lung diseases
Paola Faverio, Francesco Bini, Adriano Vaghi, Alberto Pesci

European Respiratory Review Dec 2017, 26 (146) 170082; DOI: 10.1183/16000617.0082-2017
Inhaler technique: does age matter? A systematic review
Sarah Barbara, Vicky Kritikos, Sinthia Bosnic-Anticevich

European Respiratory Review Dec 2017, 26 (146) 170055; DOI: 10.1183/16000617.0055-2017
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel

European Respiratory Review Dec 2017, 26 (146) 170057; DOI: 10.1183/16000617.0057-2017
Personalised medicine for nonsmall cell lung cancer
Céline Mascaux, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi

European Respiratory Review Dec 2017, 26 (146) 170066; DOI: 10.1183/16000617.0066-2017
Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
Rana Kanaan, Charlie Strange

European Respiratory Review Dec 2017, 26 (146) 170061; DOI: 10.1183/16000617.0061-2017
When to start and when to stop antifibrotic therapies
Sebastiano Emanuele Torrisi, Mauro Pavone, Ada Vancheri, Carlo Vancheri

European Respiratory Review Sep 2017, 26 (145) 170053; DOI: 10.1183/16000617.0053-2017

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages